logo
Share SHARE
FONT-SIZE Plus   Neg

Genzyme, Veracyte Announce U.S. Availability Of Afirma Thyroid FNA Analysis

Genzyme, a Sanofi company (SNY), and Veracyte, Inc.,said Monday that the Afirma Thyroid FNA Analysis, an innovative approach for improved thyroid nodule diagnosis, is now available to patients across the United States.

The Afirma Thyroid FNA Analysis combines expert cytopathology assessment of thyroid nodule fine needle aspiration samples, with the Afirma Gene Expression Classifier, a novel genomic test, used to resolve inconclusive results and thus help patients whose nodules are actually benign avoid unnecessary surgery.

Two independent clinical studies to date have shown that the Afirma Gene Expression Classifier can reclassify patients with indeterminate thyroid FNA results as "benign" with the same degree of accuracy as a benign cytopathology diagnosis.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Home improvement retailer Lowe's Companies Inc. (LOW) has reportedly informed about 2,400 employees that they will be laid off. The majority of the lay offs are at the store level, while other affected positions are at distribution centers, contact centers and at the company's corporate office in... The U.S. Department of Defense and Lockheed Martin Corp. are reportedly nearing a deal worth $9 billion for F-35 fighter planes. President-elect Donald Trump had earlier heavily criticized the Pentagon for overspending on defense contracts. He had specifically noted the F-35 as an example on how Lockheed... PowerBar has selected Olympic swimmer Ryan Lochte for its ad campaign to kick start the "Clean Start Pledge." The energy bar's ad campaign, which focuses on its newer line of "Clean Whey" protein bars, also encourages consumers to participate in sports and fitness exercises to improve their health. The Clean Start Pledge started on January 18.
comments powered by Disqus
Follow RTT